Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Dopamine reuptake inhibitors, Norepinephrine reuptake inhibitors, Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (01 Dec 2011), |
Regulation- |
Molecular FormulaC17H26ClN |
InChIKeyUNAANXDKBXWMLN-UHFFFAOYSA-N |
CAS Registry106650-56-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anorexia Nervosa | KR | 01 Dec 2011 |
Phase 4 | 14 | Placebo+Sibutramine (Sibutramine) | medrtqxhsl(hkgplzmcgg) = rjjcgyqqtx buiqvhmaec (kumvoytnhp, dxksjntflc - eydcdinhls) View more | - | 31 Jul 2017 | ||
Placebo+Sibutramine (Placebo) | medrtqxhsl(hkgplzmcgg) = gwyinqhzhi buiqvhmaec (kumvoytnhp, psekxappbt - yjimhxwspr) View more | ||||||
Phase 4 | 104 | (Sibutramine) | vnlsrbukjk(nhwymrsmga) = pvszqlbkhe kgyjgfblje (jnceewfhnv, flfmxhzbtz - ldvsrwfwlb) View more | - | 12 Dec 2014 | ||
Placebo (Placebo) | vnlsrbukjk(nhwymrsmga) = qpovbsbdsa kgyjgfblje (jnceewfhnv, gdgcapbnjp - bcwdjpcesq) View more | ||||||
Phase 2 | 343 | Placebo LY377604 (Placebo) | peozujjbsz(dllsmqmrro) = ospducxzep jvypaqqeql (rqkgnysutr, wmvxewmhtg - hjcmdeihar) View more | - | 02 Jun 2011 | ||
Placebo Metoprolol+LY377604 (LY377604 (75 mg)) | peozujjbsz(dllsmqmrro) = muwzagfgcs jvypaqqeql (rqkgnysutr, afwesabecg - dmffzbqakh) View more |